Skip to site menu Skip to page content
Logo Image
In Brief
Spotlight

FDA’s commissioner vouchers prompt questions about award process

Despite the FDA’s CNPV scheme generating high interest, the process around how voucher awards are prioritised remains unclear.

Latest news

TrumpRx launches to slash drug prices for cash-paying US patients

Medications, including obesity blockbusters Wegovy and Zepbound, are available on the site.

Magazine: Smart and connected packaging

In this issue: The rise of smart packaging, how AI is supporting trial acceleration, navigating the pharma supply chain, and more

Innovent and Lilly to advance new oncology and immunology medicines

Innovent will receive an upfront payment of $350m under the agreement.

Novartis starts construction on new research facility in San Diego, US

The San Diego facility forms part of the company’s $23bn US investment plan.

Have originator medicines’ list prices started to drop in the US?

According to the GlobalData service Price Intelligence (POLI) & HTA, more than 800 originator molecules still posted price hikes to their WACs and AWPs.